IBD patients are misdiagnosed with irritable bowel syndrome IBS

IBD patients are misdiagnosed with irritable bowel syndrome IBS

A new study, published in the latest issue of the UEG Journal reveals that 10 percent of inflammatory bowel disease (IBD) patients are misdiagnosed with irritable bowel syndrome (IBS), and in 3 percent of cases the misdiagnosis can persist for five or more years. The case-controlled study, conducted in the UK, assessed the proportion of patients with IBS recorded prior to the IBD diagnosis to reveal the alarming statistics.

“IBS has been estimated to affect at least 10 percent of the population in Europe and it causes distressing symptoms that disrupt normal life.” Said leading IBD researcher and United European Gastroenterology (UEG) spokesperson Dr. Michael Scharl. “We have known for some time that there are similarities between symptoms of IBS and IBD, but when it comes to diagnosis and treatment, this differs greatly.”

“Misdiagnosis is understandable, as many symptoms such as diarrhea, abdominal cramping and pain are common to both. The specific alarm symptoms for IBD, such as bloody stool, weight loss or fever, are often absent in IBD patients in the initial phase of their disease. However, increased use of fecal calprotectin testing would help doctors distinguish between inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis and non-inflammatory bowel diseases, such as irritable bowel syndrome.”

The initial misdiagnosis of IBD has serious consequences for patients, in particular those with Crohn’s disease, since delays in diagnosis is correlated with an increased risk of bowel stenosis and Crohn’s disease-related intestinal surgery. Considering that the misdiagnosis of IBD might have severe consequences for a patient’s life, the UEG is calling for increased efforts to be undertaken to screen symptomatic IBS patients for IBD. Screening tests for intestinal inflammation should be included in the work-up of all new patients presenting with diarrhea and pain.

Source: EndoNurse

IBD patients are misdiagnosed with irritable bowel syndrome IBS
Rate this post
Gut Bacteria and IBS
IBS And Gut Bacteria
What is the relationship of stress to IBS
What Is The Relationship Between IBS And Stress
Irritable Bowel Syndrome, Gut Microbiota and Probiotics
Introduction to Irritable bowel syndrome (IBS)
Group of Carbohydrates May Be Hard To Digest
Group of Carbohydrates May Be Hard To Digest
Food Components and Irritable Bowel Syndrome
Food Components and Irritable Bowel Syndrome
How to Follow The Low-FODMAP Diet
How to Follow The Low-FODMAP Diet
Probiotics for IBS - Irritable Bowel Syndrome
Probiotics for IBS – Irritable Bowel Syndrome
Yoga for IBS Relief
Yoga for IBS Relief
Famous People With IBS - Irritable Bowel Syndrome
Famous People With IBS – Irritable Bowel Syndrome
How To Solve Irritable Bowel Syndrome
How To Solve Irritable Bowel Syndrome
IBS – Irritable Bowel Syndrome
Complementary Health Practices for Irritable Bowel Syndrome Treatment
Valeant to Acquire Specialty Salix Pharma
Valeant to Acquire Specialty Salix Pharma
Food Components and Irritable Bowel Syndrome
Food Components and Irritable Bowel Syndrome
Probiotics for IBS - Irritable Bowel Syndrome
Probiotics for IBS – Irritable Bowel Syndrome
IBD patients are misdiagnosed with irritable bowel syndrome IBS
IBD patients are misdiagnosed with irritable bowel syndrome IBS
Probiotics are beneficial bacteria
Probiotics are beneficial bacteria
Breast Milk Studies May Lead to Better Probiotics Baby Formula
Breast Milk Studies May Lead to Better Probiotics Baby Formula
Probiotic Supplements May Contain Unlabeled Traces of Gluten
Some Probiotic Supplements May Contain Unlabeled Traces of Gluten
How Probiotics May Help Ease Social Anxiety
How probiotics may help ease social anxiety
Methanobrevibacter attenuation via probiotic intervention reduces flatulence in adult human: A non-randomised paired-design clinical trial of efficacy
Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice
No Preview
Better Management of Alcohol Liver Disease Using a ‘Microstructured Synbox’ System Comprising L. plantarum and EGCG